S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Sellas Shares Drop 22% After $150 Million Offering Pricing

Sellas Life Sciences Group shares fell 22% to $13.98 in premarket trading Thursday after the biopharmaceutical company priced a public offering intended to raise $150 million. The decline followed a sharp run-up: through Wednesday’s close, the stock had more than quadrupled year to date.

Sellas said late Wednesday it would sell more than 11.5 million shares of common stock at $13 each. Underwriters also received a 30-day option to buy up to about 1.73 million additional shares at the offering price, less discounts and commissions.

J.P. Morgan and TD Cowen are the lead book-running managers. The offering is expected to close Friday.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!